Daclizumab and Tresiba FlexTouch (Insulin Degludec (U-100) Prefilled Pens)
Determining the interaction of Daclizumab and Tresiba FlexTouch (Insulin Degludec (U-100) Prefilled Pens) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: n.a.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab-Tresiba FlexTouch (Insulin Degludec (U-200) Prefilled Pens)
- Daclizumab-Tretin X
- Daclizumab-Tretin X Gel
- Daclizumab-Tretin-X Cream
- Daclizumab-Tretin-X Topical
- Daclizumab-Tretinoin
- Tresiba FlexTouch (Insulin Degludec (U-100) Prefilled Pens)-Daclizumab Subcutaneous
- Tresiba FlexTouch (Insulin Degludec (U-100) Prefilled Pens)-Dacogen
- Tresiba FlexTouch (Insulin Degludec (U-100) Prefilled Pens)-Dacomitinib
- Tresiba FlexTouch (Insulin Degludec (U-100) Prefilled Pens)-Dactinomycin
- Tresiba FlexTouch (Insulin Degludec (U-100) Prefilled Pens)-Dactinomycin Injection
- Tresiba FlexTouch (Insulin Degludec (U-100) Prefilled Pens)-Dactinomycin Intravenous